MedCity News October 28, 2025
Here are some key insights to help unlock the viability of PDTs to address unmet needs throughout the healthcare ecosystem — for patients and providers alike — and how to take meaningful steps to improve the health experience.
Prescription digital therapeutics (PDTs) are having a pivotal moment. Recent studies validate their potential to both improve mental health outcomes and lower healthcare costs, while increasing efforts to bring regulatory clarity and payer interest are opening reimbursement pathways for widespread adoption.
This inflection point is enhanced by growing consumer preferences and behaviors for convenience and personalization. PDTs, which are FDA-regulated software applications used to prevent, manage, or treat medical conditions, provide just that. These preferences are not fleeting. They are fixed...
Today's Sponsors
Today's Sponsor